Test ID: SCLAM
Chlamydia Serology, Serum
Method Description
Describes how the test is performed and provides a method-specific reference
The micro-immunofluorescent antibody assay is a 2-stage "sandwich" procedure. In the first stage, the patient serum is diluted in phosphate-buffered saline, added to appropriate slide wells in contact with the substrate, and incubated. After incubation, the slide is washed in buffered saline to remove unbound serum antibodies. In the second stage, each antigen well is overlaid with fluorescein-labeled antibody to IgG or IgM. The slide is incubated, allowing antigen-antibody complexes to react with the fluorescein-labeled anti-IgG. After the slide is washed, dried, and mounted, it is examined using fluorescence microscopy. Positive reactions appear as bright apple-green fluorescent elementary bodies with a background matrix of yolk sac. Semiquantitative endpoint titers are obtained by testing serial dilutions of positive specimens. (Schachter J: Chlamydiae [Psittacosis-Lymphogranuloma Venereum-Trachome Group]. In Manual of Clinical Microbiology. 4th edition. Edited by E Lennette, A Balows, W Hausler, H Shadomy. Washington, DC, ASM Press, 1985, pp 856-861; Smith T: Chlamydia. In Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections. 6th edition. Edited by N Schmidt, R Emmons. Washington, DC, APHA, 1989, pp 1165-1198)
Day(s) and Time(s) Test Performed
Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday through Saturday; 9 a.m.


